Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

por Naimi, Adel, Mohammed, Rebar N., Raji, Ahmed, Chupradit, Supat, Yumashev, Alexei Valerievich, Suksatan, Wanich, Shalaby, Mohammed Nader, Thangavelu, Lakshmi, Kamrava, Siavash, Shomali, Navid, Sohrabi, Armin D., Adili, Ali, Noroozi-Aghideh, Ali, Razeghian, Ehsan
Publicado 2022